Press release
Rising Alzheimer's Cases Propel Growth Of The Market Driver: Leading Transformation in the Donepezil Market in 2025
Donepezil
The increasing prevalence of Alzheimer's disease is expected to propel the growth of the donepezil market. Alzheimer's disease, a progressive neurological disorder, is becoming more prevalent due to factors like an aging population, lifestyle changes, and genetic predispositions. Donepezil is a well-known treatment that helps manage symptoms of Alzheimer's by improving cognitive function. As the number of individuals diagnosed with Alzheimer's continues to rise-the Alzheimer's Association reports an increase from 6.5 million to 6.9 million cases in the U.S. alone by 2024-the demand for medications like donepezil will continue to grow, driving market expansion.
Get Your Donepezil Market Report Here:
https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report
What is the projected compound annual growth rate (CAGR) of the donepezil market from 2025 to 2034, and what factors influence it?
The donepezil market has grown steadily, increasing from $1.00 billion in 2024 to $1.05 billion in 2025 at a CAGR of 5.1%. Historical growth has been driven by the increasing prevalence of Alzheimer's disease, a growing geriatric population, rising government spending and programs, greater awareness of neurodegenerative disorders, and rising demand for high-quality nucleic acid samples.
The donepezil market is projected to see steady growth, reaching $1.27 billion by 2029 with a CAGR of 4.9%. Growth factors include rising healthcare expenditures, increasing efforts to diagnose Alzheimer's at earlier stages, growing demand for combination therapies, larger investments in healthcare infrastructure, and greater awareness of neurodegenerative diseases. Industry trends include innovations in drug formulations and delivery methods, technological advancements, the introduction of novel dosage forms and formulations, approvals of generic donepezil versions, and the expansion of advanced research facilities.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
How are the latest trends influencing the growth of the donepezil market?
In the donepezil market, companies are innovating with advanced drug delivery systems such as the donepezil transdermal system to improve patient compliance and treatment effectiveness. For instance, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, launched the Adlarity transdermal system to treat Alzheimer's disease. This new formulation delivers donepezil through the skin, bypassing the digestive system and reducing the likelihood of gastrointestinal side effects, offering a more convenient and effective treatment option for Alzheimer's patients and their caregivers.
What are the major segments of the donepezil market and their role in driving growth?
The donepezil market covered in this report is segmented -
1) By Type: 5mg, 10mg, 23mg
2) By Route Of Administration: Oral, Transdermal
3) By Application: Hospitals, Clinics, Drugstore
Subsegments:
1) By 5mg: Immediate-Release 5mg, Orally Disintegrating 5mg
2) By 10mg: Immediate-Release 10mg, Orally Disintegrating 10mg
3) By 23mg: Extended-Release 23mg, Film-Coated 23mg
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21174
Which regions are key players in the growth of the donepezil market?
North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the donepezil market?
Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
What Is Covered In The Donepezil Global Market Report?
•Market Size Forecast: Examine the donepezil market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the donepezil market for a structured understanding.
•Key Players Overview: Analyze major players in the donepezil market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the donepezil market.
•Segment Contributions: Evaluate how different segments drive overall growth in the donepezil market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the donepezil market.
•Industry Challenges: Identify potential risks and obstacles affecting the donepezil market.
•Competitive Landscape: Review strategic developments in the donepezil market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Alzheimer's Cases Propel Growth Of The Market Driver: Leading Transformation in the Donepezil Market in 2025 here
News-ID: 3936923 • Views: …
More Releases from The Business Research Company
Top Trends Transforming the Nebulizers Market Landscape in 2025: FDA-Approved Sm …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nebulizers Industry Market Size Be by 2025?
The size of the nebulizers market has witnessed robust growth in the past few years. Its size is forecasted to expand from $1.31 billion in 2024 to $1.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Vitreoretinal Surgery Devices Market Expansion Continues, with Forecast Valuatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Vitreoretinal Surgery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for vitreoretinal surgery devices has seen a steady expansion. The market is projected to rise from $2.05 billion in 2024 to $2.13 billion in 2025, implying a compound…
Key Factor Supporting Medical Coding Market Development in 2025: Surge In Medica …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Medical Coding Market Size By 2025?
The market size of medical coding has seen robust expansion in the past few years. Its size will increase from $17.78 billion in 2024 to $18.88 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The…
Emerging Trends to Drive Laboratory Automation Systems Market Growth at 7.6% CAG …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Laboratory Automation Systems Market Size Growth Forecast: What to Expect by 2025?
The market size for laboratory automation systems has seen a consistent growth in recent years. It's projected to increase from $5.59 billion in 2024 to about $5.85 billion in 2025, with a compound annual growth rate (CAGR)…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
